|
Index of reports
> Cases resulting in other serious reactions (57)
> Cases with Aspartate Aminotransferase Increased (8)
Below is the selection of adverse event reports related to Amaryl (Glimepiride) that includes cases resulting in other serious reactions where reactions include aspartate aminotransferase increased.
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-31
Patient: male
Adverse reactions / side effects: Abdominal Pain, Vomiting, Alanine Aminotransferase Increased, Liver Disorder, Malaise, Diarrhoea, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased, Anorexia, Cough
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-23
End date: 2007-07-03
Miglitol Tablet
Dosage: daily dose:150mg
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-01-27
End date: 2007-06-23
Other drugs received by patient: Glucobay; Valsartan; Lansoprazole; Lendormin; Glyburide
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-26
Patient: male
Adverse reactions / side effects: Abdominal Pain, Malaise, Diarrhoea, Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-23
End date: 2007-07-03
Miglitol Tablet
Dosage: daily dose:150mg
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-01-27
End date: 2007-06-23
Other drugs received by patient: Glucobay; Valsartan; Lansoprazole; Lendormin; Glyburide
Adverse event in male receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-06
Patient: male
Adverse reactions / side effects: Abdominal Pain, Malaise, Diarrhoea, Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-03-23
End date: 2007-07-03
Miglitol Tablet
Dosage: daily dose:150mg
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-01-27
End date: 2007-06-23
Other drugs received by patient: Glucobay; Valsartan; Lansoprazole; Lendormin; Daonil
Adverse event in 60 year old male receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from Canada on 2007-10-01
Patient: 60 year old male
Adverse reactions / side effects: Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Drug Interaction
Suspect drug(s):
Altace
Dosage: 10mg per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Amaryl
Dosage: 4mg per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Atacand HCT
Dosage: 1tab per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Avandamet
Dosage: 2mg twice per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Imipramine
Dosage: 10mg twice per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lipitor
Dosage: 10mg per day
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-03
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 58 year old female receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from Canada on 2007-06-11
Patient: 58 year old female
Adverse reactions / side effects: Confusional State, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Abnormal, Dehydration, Hypoglycaemia, Blood Creatinine Increased
Suspect drug(s):
Amaryl
Indication: Drug USE FOR Unknown Indication
Avandia
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Crestor
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-06-06
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-05-23
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Muscle Twitching, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Oedema, Blood Sodium Increased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
|
